Pliant Therapeutics Announces Interim Data From PLN-101095

Reuters
2025.12.04 12:39
portai
I'm PortAI, I can summarize articles.

Pliant Therapeutics Inc :PLIANT THERAPEUTICS ANNOUNCES INTERIM DATA FROM PLN-101095 IN PATIENTS WITH IMMUNE CHECKPOINT INHIBITOR-REFRACTORY ADVANCED SOLID TUMORSPLIANT THERAPEUTICS INC: TO ACCELERATE DEVELOPMENT OF PLN-101095 WITH INITIATION OF A PHASE 1B EXPANSION TRIAL IN 2026

Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer